글로벌 유방 영상 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

유방 영상 시장 분석

글로벌 유방 영상 시장은 예측 기간 동안 빠르게 증가할 것으로 추산됩니다. 자궁 경부암 다음으로 유방암은 여성 사망 원인 중 두 번째로 높습니다. 연구 조사에 따르면 유방암은 여성에게 가장 흔한 암으로, 2012년에 167만 건의 신규 사례가 확인되었으며 2020년까지 197만 명 이상이 걸릴 것으로 예상됩니다. 결과적으로 유방 영상 기술의 개발은 유방암 발생률과 이와 관련된 위험 요소를 줄이는 데 중요합니다. 결과적으로 유방암 유병률의 증가는  유방  영상 기술의 시장 점유율을 높일 것으로 예상됩니다. 따라서 시장에서 유방 영상에 대한 수요가 증가합니다.  

유방 영상 시장 규모

글로벌 유방 영상 시장 규모는 2023년에 47억 9천만 달러로 평가되었으며, 2031년까지 95억 1천만 달러에 도달할 것으로 예상됩니다. 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.97%입니다.

보고 범위 및 시장 세분화       

유방 영상 시장 정의

Breast imaging is a type of medical technology that is used to identify or diagnose breast cancer in women. By giving radiological pictures of women's breasts, breast imaging medical technology aids in diagnosing many breast-related disorders. Nuclear imaging, mammography, breast ultrasonography, and magnetic resonance imaging (MRI) are the types of breast imaging technology. The main goal of this test is to detect breast cancer and other breast-related disorders at the earliest possible stage, when they are still treatable.

Breast Imaging Market Dynamics

Drivers

• Increasing prevalence of breast cancer will drive the market's growth rate

Breast imaging aids in the diagnosis of breast cancer and other related problems, hence the market is expected to grow greatly as the number of cases of breast cancer rises.

Additionally, the rising number of government initiatives to spread awareness among people about the early detection of breast cancer will be a major driver influencing the breast imaging market's growth rate. Another significant factor resulting in the expansion of market is the advancement of technology in breast imaging modalities. Furthermore, rising geriatric population and increasing level of public-private investments, grants and funding are the major drivers that will enhance the growth of market.

Opportunities

• Growth in R&D activities will boost many market opportunities during the forecast period  

Moreover, the rise in the number of research and development activities will provide beneficial opportunities for The breast imaging market growth. Along with this increase in technological development in the field of medical devices will further expand the breast imaging market's growth rate in the future.

• Emerging markets of breast imaging is the major driver creating new market opportunities

Emerging markets such as Asia-Pacific are likely to boost the industry in the future. In the region, breast cancer is becoming more common. In developing nations, efficient early detection of breast cancer is critical, as the majority of breast cancer patients are detected later, resulting in higher mortality rates.

Restraints/Challenges

• Associated risk from radiation exposure will create challenges for the market growth

Breast imaging is crucial for detecting breast cancer in its early stages. Several breast imaging modalities, however, use ionizing radiation for diagnosis. Ionizing radiation is used in digital mammography (DM) and digital breast tomosynthesis (DBT), as well as possible new breast screening techniques including contrast-enhanced mammography (CEM), whole-breast CT (WBCT), breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), and positron emission mammography (PEM). Therefore, rising risk from radiation exposure will further challenge the breast imaging market.  

On the other hand, high cost associated with imaging systems or technology will obstruct the market growth. Also, unfavourable reimbursement scenario in developing and underdeveloped economies will pose a major challenge for breast imaging market. However, strict regulatory approval processes and emergence of unfavourable conditions due to COVID-19 outbreak will act as restrain and further impede the growth rate of market during the forecast period of 2024-2031.

This breast imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on The breast imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Breast Imaging Market

The COVID-19 pandemic had a negative influence on a number of markets around the world. It also had a considerable impact on breast imaging procedures. Lockdowns and other restrictions implemented by governments throughout the world have impeded market demand. Furthermore, governments have implemented restrictions to suspend elective and non-urgent medical treatments in order to slow the spread of the virus.

Furthermore, the fear of catching the virus led to a large drop in breast imaging diagnosis, particularly during COVID-19's first wave in 2020. According to research released by Breast Cancer Now (UK) in September 2020, COVID-19 has caused over 9,86,000 women in the UK to skip their breast screening appointments. According to a paper published in the Eurasian Journal of Medical Investigation in 2020, there was a 64 percent decline in mammography, a 47.7% decrease in breast ultrasound, and a 41.7 percent decrease in breast MRI cases in Turkey when compared to data from 2019. Hence, COVID-19 had severely impacted the breast imaging market.

Breast Imaging Market Scope

The breast imaging market is segmented on the basis of technologies and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technologies

• Ionizing Breast Imaging Technologies
• Non-Ionizing Breast Imaging Technologies

The breast imaging market is segmented on the basis of technologies into ionizing breast imaging technologies and non-ionizing breast imaging technologies. Ionizing breast imaging technologies is further segmented into FFDM, Analog, 3D Mammogram, CT, CBCT. Non-ionizing breast imaging technologies is segmented into breast ultrasound, breast MRI, AWBU, Breast thermography.

End User

• Hospital
• Diagnostic Imaging Centre
• Others

On the basis of end user, The breast imaging market is segmented into hospital, diagnostic imaging center and others.

Breast Imaging Market Regional Analysis

The breast imaging market is analysed and market size insights and trends are provided by country, technologies and end user as referenced above.

The countries covered in The breast imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates The breast imaging market because of the growing adoption of advanced healthcare imaging technologies and major market players in this region. Additionally, the increasing prevalence of breast cancer will further enhance the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to the rising patient pool in this region. Also, rising geriatric population and surging level of personal disposable income will propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Breast Imaging Market Share

유방 영상 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 있습니다. 위에 제공된 데이터 포인트는 유방 영상 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 유방 영상 시장 리더는 다음과 같습니다.

• Koninklijke Philips NV(네덜란드)
• 히타치 주식회사(일본)
• 지멘스 헬스케어 GmbH(독일)
• CANON MEDICAL SYSTEMS CORPORATION(일본)
• 제너럴 일렉트릭(미국)
• Aspect Imaging Ltd(이스라엘)
• 브루커(미국)
• 오로라 헬스케어(미국)
• FONAR Corp. (미국)
• ESAOTE SPA(이탈리아)
• Neusoft Corporation(중국)
• TOSHIBA CORPORATION(일본)
• Sanrad Medical Systems Private Limited(인도)
• 후지필름 홀딩스 주식회사(일본)
• ONEX Corporation(캐나다)
• 홀로직 주식회사(미국)
• 심천 Mindray Bio-Medical Electronics Co., Ltd. (중국)
• 이미징 진단 시스템(Imaging Diagnostic Systems, Inc.) (미국)
• Agfa-Gevaert 그룹(벨기에)
• Koning Health(중국)

유방 영상 시장의 최신 동향

• 2020년 11월, Densitas Inc.는 Mammography Educators, LLC와의 파트너십을 발표했습니다. 이 파트너십은 유방촬영 시설에서 비즈니스 연속성을 지원하는 인공지능 기반 텔레헬스 기술자 교육 플랫폼을 출시하는 것을 목표로 합니다.
• 2020년 10월, Hologic, Inc.는 Genius AI가 유럽에서 구동하는 3DQuorum Imaging Technology의 상업적 출시를 발표했습니다. 회사의 공개에 따르면, 3DQuorum Imaging Technology는 Genius AI 구동 분석을 사용하여 고해상도 3D 데이터를 재구성하여 사진 해석 시간을 줄이는 데 도움이 됩니다.

SKU-13947